observed that cancer cells suppressing Nrf2 expression are susceptible to ferroptosis inducers, while cancer cells with elevated Nrf2 expression resist ferroptosis initiation and execution by upregulating system XC−. This evidence concerns the gene NFE2L2 and cancer.